News
Largest study on retinal imaging in Parkinson’s identifies markers of Parkinson’s in eye scans with the help of artificial intelligence (AI).
The AI examined images of brain cells and was able to identify changes in key areas of the cell that are characteristic of the different known mechanisms that cause Parkinson’s.
On 4 August, the UK government published a plan to address the NHS care backlog in England and give people more choice in who provides their care. We look at what it could mean for people with Parkinson’s.
Parkinson’s UK was chosen as The Access Group's charity of the year in the UK for 2022/2023.
80-year-old Jon Goodwin was diagnosed with Parkinson’s 9 years ago. Next month, he’s travelling into space.
In May, 2 people with Parkinson’s shared their experiences of pharmacy services in England. Their views have shaped a new parliamentary report.
On 12 July, 3 All-Party Parliamentary Groups met MPs to highlight the challenges people living with Parkinson’s, multiple sclerosis, Crohn’s and colitis face accessing vital disability support.
Created in collaboration with the Parkinson’s community and University College London (UCL), we’ve published new information on thinking and memory changes for people with Parkinson’s.
Updated trial results show NLX-112 could treat motor symptoms as well as dyskinesia. If further trials are successful, we could have a valuable new Parkinson’s drug by 2030.
The prime minister announced the NHS long-term workforce plan for England. There are some positive changes, but it's still not clear how people with Parkinson's will receive the specialist care they urgently need.